339276-36-7 Usage
Chemical structure
A piperidinecarboxylic acid derivative with a 6-chloro-3-pyridazinyl ring attached to the piperidine nitrogen.
Field of application
Primarily used in the field of medicinal chemistry.
Pharmacological activities
Demonstrated potential as an antagonist of certain receptors in the central nervous system.
Potential applications
Development of new drugs for the treatment of various neurological and psychiatric disorders.
Research tool
May be used in the study of receptor-ligand interactions and the development of novel therapeutic agents.
Molecular weight
Approximately 248.7 g/mol (calculated from the molecular formula).
Functional groups
Contains a carboxylic acid (-COOH) group, a piperidine ring, and a 6-chloro-3-pyridazinyl ring.
Solubility
The solubility of this compound is not explicitly mentioned in the material provided, but it can be inferred that it may be soluble in polar solvents like water or methanol due to the presence of the carboxylic acid group.
Stability
The stability of 1-(6-CHLORO-3-PYRIDAZINYL)-4-PIPERIDINECARBOXYLIC ACID is not mentioned in the material provided, but it is generally expected to be stable under standard laboratory conditions, as it is a small organic molecule.
Check Digit Verification of cas no
The CAS Registry Mumber 339276-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,9,2,7 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 339276-36:
(8*3)+(7*3)+(6*9)+(5*2)+(4*7)+(3*6)+(2*3)+(1*6)=167
167 % 10 = 7
So 339276-36-7 is a valid CAS Registry Number.
339276-36-7Relevant articles and documents
PIPERIDINE/CYCLOHEXANE CARBOXAMIDE DERIVATIVES FOR USE AS VANILLOID RECEPTOR MODULATORS
-
Page/Page column 13, (2010/02/10)
Certain compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, P, P', X, m and n are as defined in the specification, a process for preparing such compounds, a pharmaceutical composition c
